Loading...
Not a good buy right now for an impatient trader. SSRM just suffered a sharp -15.03% regular-session drop (post-market 23.05, +1.14%), and price is now sitting right around/below near-term support (S1=23.172) with the next support down at S2=21.671. While longer-term trend structure (SMA_5 > SMA_20 > SMA_200) and fundamentals/news are improving, the near-term tape is still fragile and the pattern-based forecast skews negative over the next day/week/month. I would HOLD (not buy) until price reclaims/holds above 23.2 and starts basing, or until it decisively reclaims the pivot (25.6).
Trend/structure: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting the broader trend has been constructive, but today’s -15% shock move signals a near-term trend break/volatility regime. Momentum: RSI_6 = 32.24 (near oversold/weak momentum). MACD histogram is still >0 (0.0824) but positively contracting, implying upside momentum is fading rather than accelerating. Levels: Pivot 25.602 is the key reclaim level for bulls. Immediate support S1=23.172 (price ~23.05 is slightly below), next support S2=21.671. Resistance R1=28.031. Near-term odds (pattern analogs): 50% probability skew suggests -4.66% (next day), -4.91% (next week), -6.74% (next month), reinforcing that immediate follow-through risk remains.
Intellectia Proprietary Trading Signals

signals the market expects large moves; that often keeps pressure on the stock until a base forms.
Latest quarter: 2025/Q3. Growth was strong: Revenue $385.839M (+49.92% YoY), Net Income $65.441M (+519.88% YoY), EPS $0.31 (+520% YoY). Gross margin improved to 40.08 (+109.40% YoY). This indicates a sharp profitability/operating leverage upswing versus the prior year, supporting the longer-term bull case even though the near-term trading picture is currently unstable.
Recent trend: Ratings/targets have generally moved up in January 2026.